Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

VRAX

Virax Biolabs Group Ltd

CIK 0001885827 · Nasdaq

NasdaqHealth CareIn Vitro & In Vivo Diagnostic Substances
$6.36
↑ 3.18 (100.00%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 2/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Technicals; Risks: Fundamentals; Excluded: Ownership, Options (no data)

Key stats

Market Cap
$27.61M
P/E Ratio
-4.55
EPS
-1.62
Dividend Yield
Not covered
52W Position
48%
Beta
-11.51

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
5.06
P/S
4,361.84
EV/Revenue
3,693.87
ROE
-111.1%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 48%
$0.10$13.19

Latest Financials

2025-03-31 FY
Revenue
$6.33K
Net Income
-$6.07M
Total Assets
$6.43M
Free Cash Flow
-$5.17M

Recent news